Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Single Cell Multi-Omics Market: Focus on Global Single Cell Multi-Omics Market by Product, Type, Workflow, End-User 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast: 2019-2025

Published by BIS Research Inc. Product code 872615
Published Content info 331 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Single Cell Multi-Omics Market: Focus on Global Single Cell Multi-Omics Market by Product, Type, Workflow, End-User 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast: 2019-2025
Published: June 12, 2019 Content info: 331 Pages
Description

Global Single Cell Multi-Omics Market to Reach $5.32 Billion by 2025

Key Questions Answered in this Report:

  • What was the total revenue generated by the global single cell multi-omics market and how is it expected to grow during 2019-2025?
  • What are the major driving forces, trends, challenges and growth opportunities that can tend to increase the demand for the global single cell multi-omics market during the forecast period, 2019-2025?
  • How each segment of the global single cell multi-omics market by 2025? What was the revenue generated by the global single cell multi-omics market by

Type, such as single cell genomics market, single cell proteomics and transcriptomics market, and single cell metabolomics market in 2018?

Product, such as systems & instruments and consumables in 2018?

Workflow, such as single cell isolation, single cell preparation, and single cell analysis in 2018?

Application, such as oncology, immunology, neurology, microbiology, stem cell, cell biology, and others in 2018?

Region, such as North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World in 2018?

  • Who are the key manufacturers and service providers in the global single cell multi-omics market, and what are their contributions?
  • What is the growth potential of each major single cell multi-omics manufacturer and service provider?
  • What are the key development strategies which are implemented by major players in order to sustain in the competitive market?
  • What are the key regulatory implications in developed and developing regions for single cell multi-omics?

Global Single Cell Multi-Omics Market Forecast

The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.

This growth has been primarily attributed to the major drivers in this market such as the increased need for non-invasive diagnosis, advancements in single cell sequencing technique and increase in adoption of personalized medicine. These individualized care regimes are improving quality of life of the patients and reducing economic, societal, and clinical burden, projecting a future of prosperity.

The applications of single cell multi-omics primarily include oncology, cell biology, neurology, stem cell and immunology, among others. Aside from the discovery of effective biomarkers for the development of efficient targeted drug therapy, single cell approach also facilitates gene expression and protein expression analyses in an individual cell. Research and academic organizations, biotechnology and biopharmaceutical companies, and diagnostic centers, among others, are prominent end users of single cell multi-omics solutions.

Expert Quote on Global Single Cell Multi-Omics Market

"North America is the leading contributor of the global single cell multi-omics market and contributed approximately 45.40% to the global market value in 2019. This region is anticipated to grow at a double digit CAGR, during the forecast period 2019-2025 and continue to dominate the market in 2025 as well. The Europe region also contributed a significant share of 26.52% to the market in 2019 and is anticipated to grow at a substantial CAGR, during the forecast period."

Scope of the Market Intelligence on Global Single Cell Multi-Omics Market

This research report aims at answering various aspects of the global single cell multi-omics market with the help of the key factors driving the market, the restraints, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with the Porter's Five Forces Analysis for a comprehensive understanding of the global single cell multi-omics market. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple geographical regions, growth of single cell multi-omics market in each region for different applications, and the key strategies and developments by the prominent single cell multi-omics manufacturers and service providers.

Market Segmentation

The market has been segmented into 'type', 'workflow', 'product', 'applications', 'end users', and 'region'. The scope of this report is centered upon conducting a detailed study of the products and services allied with the single cell multi-omics market. In addition, the study also includes the exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each service, application, technology, end user, region, and company, as well as other vital information with respect to global single cell multi-omics market.

Based on region, the global single cell multi-omics market is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW). North America is the leading contributor to the global single cell multi-omics market and was responsible for a 45.8% share of the global market values in 2018. However, the Asia-Pacific region is expected to grow at the fastest pace among all other regions with double digit CAGR, during the forecast period 2019-2025.

Key Companies in the Global Single Cell Multi-Omics Market

The key players who have been contributing significantly to the global single cell multi-omics market include 10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V., among others.

Table of Contents
Product Code: BH135A

Table of Contents

Executive Summary

1 Single Cell Multi-Omics Market: Global Perspective

  • 1.1 Introduction
    • 1.1.1 Single Cell Sequencing Data and Bioinformatics Analysis
      • 1.1.1.1 Analysis of Single Cell Genomic Data
      • 1.1.1.2 Analysis of Single Cell Transcriptome Sequencing
      • 1.1.1.3 Analysis of Single Cell Methylome Sequencing
      • 1.1.1.4 Analysis of Singe Cell Epigenome Sequencing
  • 1.2 Global Single Cell Multi-Omics Market Size, 2018-2025
  • 1.3 Single Cell Multi-Omics Technologies and Advancement in Recent Past, 2010-2017
    • 1.3.1 Advances in Single Cell Multi-Omics Sequencing Technologies:
      • 1.3.1.1 Single Cell RNA Sequencing Methods
      • 1.3.1.2 Single Cell DNA Sequencing Methods
      • 1.3.1.3 Single Cell Epigenetic Sequencing Methods
    • 1.3.2 Technological Development in Single Cell Sequencing
      • 1.3.2.1 Advancements in Imaging Techniques for Single Cell Sequencing
      • 1.3.2.2 Advancements in Single Cell Collection and Analysis System
  • 1.4 Single Cell Trends and Key Innovators
    • 1.4.1 Recent Trends in Single Cell
      • 1.4.1.1 Use of CRISPR in Single Cell Genomics
      • 1.4.1.2 Application of Single Cell Genomics in Plants
      • 1.4.1.3 Application of Single Cell Genomics in Animals
      • 1.4.1.4 Single Cell Multi-Omics
      • 1.4.1.5 Computational Analysis in Single Cell Genomics
    • 1.4.2 Key innovators in Single Cell Multi-Omics
  • 1.5 Single Cell Multi-Omics Research Funding
  • 1.6 Single Cell Multi-Omics Publications and its Regional Distribution
  • 1.7 Role of Regulatory Bodies and Consortium in Single Cell Multi-Omics Market
  • 1.8 Key Companies in Single Cell Multi-Omics Market and their Contributions

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Impact Analysis
  • 2.3 Market Drivers
    • 2.3.1 Need for Non-Invasive Diagnosis
    • 2.3.2 Advancements in Single Cell Sequencing Techniques
    • 2.3.3 Increase in Adoption of Personalized Medicine
  • 2.4 Market Restraints
    • 2.4.1 Lack of Tools for Computational Analysis
    • 2.4.2 High Capital Requirement
    • 2.4.3 Lack of Infrastructure and Expertise
  • 2.5 Opportunities
    • 2.5.1 Expansion into Emerging Markets
    • 2.5.2 Expansion into New Research Application
    • 2.5.3 Expansion of the Product Portfolio

3 Addressable Market Size and Potential Growth

  • 3.1 North America
  • 3.2 Europe
  • 3.3 Asia-Pacific
  • 3.4 Latin America
  • 3.5 Rest-of-the-World

4 Industry Insights

  • 4.1 Key Strategies and Developments
    • 4.1.1 Product Launch
    • 4.1.2 Synergistic Activities
    • 4.1.3 Mergers and Acquisitions
    • 4.1.4 Funding
    • 4.1.5 Legal Requirements and Regulations
      • 4.1.5.1 Legal Requirements and Framework in U.S.
      • 4.1.5.2 Legal Requirements and Regulations in Europe
      • 4.1.5.3 Legal Requirements and Framework in Asia-Pacific

4.1.5.3.1 China

4.1.5.3.2 Japan

  • 4.2 Industry Attractiveness
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry

5 Global Single Cell Multi-Omics Market by Type, 2018-2025 ($Millions)

  • 5.1 Single Cell Genomics
    • 5.1.1 Overview
    • 5.1.2 Market Size and Forecast
    • 5.1.3 Key Developments
    • 5.1.4 Competitive Insights
  • 5.2 Single Cell Transcriptomics and Proteomics
    • 5.2.1 Overview
    • 5.2.2 Market Size and Forecast
    • 5.2.3 Key Developments
    • 5.2.4 Competitive Insights
  • 5.3 Single Cell Metabolomics
    • 5.3.1 Overview
    • 5.3.2 Market Size and Forecast
    • 5.3.3 Key Developments
    • 5.3.4 Competitive Insights

6 Global Single Cell Multi-Omics Market (by Product), 2018-2025 ($Million)

  • 6.1 Instruments
    • 6.1.1 Flow Cytometers/FACS Instruments
    • 6.1.2 Next-Generation Sequencing Systems
    • 6.1.3 Polymerase Chain Reaction
    • 6.1.4 Microscopes
    • 6.1.5 Microarray Systems
    • 6.1.6 Spectrophotometers
    • 6.1.7 Microplate Readers
    • 6.1.8 Cell Counters
    • 6.1.9 Cell sorters
    • 6.1.10 Others
  • 6.2 Consumables
    • 6.2.1 Beads
    • 6.2.2 Microplates
    • 6.2.3 Assay kits
    • 6.2.4 Reagents
    • 6.2.5 Others

7 Global Single Cell Multi-Omics Market by Workflow, 2018-2025 ($Millions)

  • 7.1 Single Cell Isolation
    • 7.1.1 Flow Cytometry/FACS
    • 7.1.2 Manual Cell Picking
    • 7.1.3 Magnetic-activated Cell Sorting
    • 7.1.4 Laser Microdissection
    • 7.1.5 Random seeding/ Limiting Dilution
    • 7.1.6 Microfluidics
    • 7.1.7 Others
  • 7.2 Single Cell Preparation
    • 7.2.1 Microfluidics
    • 7.2.2 Whole genome amplification
    • 7.2.3 Single Cell RNA-seq
    • 7.2.4 Others
  • 7.3 Single Cell Analysis
    • 7.3.1 Polymerase Chain Reaction
    • 7.3.2 Next Generation Sequencing
    • 7.3.3 Microarray
    • 7.3.4 Multiple Displacement Amplification
    • 7.3.5 Multiple Annealing and Looping-based Amplification Cycles (MALBAC)
    • 7.3.6 Flow Cytometry
    • 7.3.7 Mass Spectrometry
    • 7.3.8 Microscopy (Fluorescence, Phase and Bright Field)
    • 7.3.9 Microfluidics
    • 7.3.10 Others
      • 7.3.10.1 In-Vitro Transcription
      • 7.3.10.2 phi29 DNA Polymerase

7.3.10.2.1 MA

7.3.10.2.2 TTA

8 Global Single Cell Multi-Omics Market by End User, 2018-2025 ($Millions)

  • 8.1 Overview
  • 8.2 Research and Academic Laboratories
  • 8.3 Biopharmaceutical and Biotech Companies
  • 8.4 Others (Hospitals, Clinics, and Diagnostic Labs)

9 Global Single Cell Multi-Omics Market (By Region)

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 U.K.
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Japan
    • 9.4.2 Singapore
    • 9.4.3 India
    • 9.4.4 China
    • 9.4.5 South Korea
    • 9.4.6 Australia
    • 9.4.7 Rest-of-APAC
  • 9.5 Latin America
    • 9.5.1 Mexico
    • 9.5.2 Brazil
    • 9.5.3 Rest-of-Latin America
  • 9.6 Rest-of-the-World

10 Global Single Cell Multi-Omics Market (by Application), $Million, 2018-2025

  • 10.1 Oncology
  • 10.2 Immunology
  • 10.3 Neurology
  • 10.4 Microbiology
  • 10.5 Stem Cell
  • 10.6 Cell Biology
  • 10.7 Others

11 Competitive Landscape

  • 11.1 Growth Share Analysis
  • 11.2 Market Share Analysis
  • 11.3 Competitor Value Chain Analysis
  • 11.4 Competitor Supply Chain Analysis

12 Company Profiles

  • 12.1 Overview
  • 12.2 1CellBio
    • 12.2.1 Company Overview
    • 12.2.2 Role of 1CellBio in the Global Single Cell Multi-Omics Market
    • 12.2.3 SWOT Analysis
  • 12.3 10x Genomics Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of 10x Genomics Inc. in the Global Single Cell Multi-Omics Market
    • 12.3.3 SWOT Analysis
  • 12.4 Becton, Dickinson and Company
    • 12.4.1 Company Overview
    • 12.4.2 Role of Becton, Dickinson and Company in the Global Single Cell Multi-Omics Market
    • 12.4.3 Key Insights about Financial Health of the Company
    • 12.4.4 SWOT Analysis
  • 12.5 Bio-Rad Laboratories, Inc.
    • 12.5.1 Company Overview
    • 12.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell Multi-Omics Market
    • 12.5.3 Key Insights about Financial Health Company
    • 12.5.4 SWOT Analysis
  • 12.6 BGI Genomics Co. Ltd.
    • 12.6.1 Company Overview
    • 12.6.2 Role of BGI in Single-Cell Multi-Omics Market
    • 12.6.3 SWOT Analysis
  • 12.7 Celsee Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Role of Celsee Inc. in the Global Single Cell Multi-Omics Market
    • 12.7.3 SWOT Analysis
  • 12.8 Fluidigm Corporation
    • 12.8.1 Company Overview
    • 12.8.2 Role of Fluidigm Corporation in the Global Single Cell Multi-Omics Market
    • 12.8.3 Key Insights about Financial Health of the Company
    • 12.8.4 SWOT ANALYSIS
  • 12.9 Fluxion Biosciences
    • 12.9.1 Company Overview
    • 12.9.2 Role of Fluxion Biosciences in the Global Single Cell Multi-Omics Market
    • 12.9.3 SWOT Analysis
  • 12.10 GE
    • 12.10.1 Company Overview
    • 12.10.2 Role of GE Healthcare in the Global Single Cell Multi-Omics Market
    • 12.10.3 Key Insights about Financial Health Company
    • 12.10.4 SWOT Analysis
  • 12.11 Mission Bio
    • 12.11.1 Company Overview
    • 12.11.2 Role of Mission Bio in the Single Cell Multi-Omics Market
    • 12.11.3 SWOT Analysis
  • 12.12 NanoString Technologies, Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Role of NanoString Technologies, Inc. in the Global Single Cell Multi-Omics Market
    • 12.12.3 Key Insights about Financial Health of the Company
    • 12.12.4 SWOT Analysis
  • 12.13 Illumina, Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Role Illumina, Inc. in the Global Single Cell Multi-Omics Market
    • 12.13.3 Key Insights about Financial Health Company
    • 12.13.4 SWOT Analysis
  • 12.14 PerkinElmer, Inc.
    • 12.14.1 Company Overview
    • 12.14.2 Role of PerkinElmer, Inc. in the Global Single Cell Multi-Omics Market
    • 12.14.3 Key Insights about Financial Health of Company
    • 12.14.4 SWOT Analysis
  • 12.15 QIAGEN N.V.
    • 12.15.1 Company Overview
    • 12.15.2 Role of QIAGEN N.V. in the Global Single Cell Multi-Omics Market
    • 12.15.3 Key Insights about Financial Health of Company
    • 12.15.4 SWOT Analysis
  • 12.16 Takara Bio, Inc.
    • 12.16.1 Company Overview
    • 12.16.2 Role of Takara Bio, Inc. in the Global Single Cell Multi-Omics Market
    • 12.16.3 Key Insights about Financial Health of Company
    • 12.16.4 SWOT Analysis

13 Research Scope and Methodology

  • 13.1 Research Scope
  • 13.2 Global Single Cell Multi-Omics Market: Research Methodology

List of Tables

  • Table 1: Methods for Single Cell Multi-Omics
  • Table 1.1: Single Cell Multi-Omics Research Funding
  • Table 1.2: List of Publication of Single Cell Multi-Omics:
  • Table 1.3: List of Publication of Single Cell Multi-Omics at Regional Level:
  • Table 1.4: Regulatory Bodies and Consortiums of Single Cell Multi-Omics Market
  • Table 1.5: Major Contributions by Key Players in the Market
  • Table 2.1: Impact Analysis
  • Table 2.2: Impact Analysis: Market Restraints
  • Table 4.1: Classification of Directive Groups IVDs
  • Table 5.1: Key Developments in Single Cell Genomic Market
  • Table 5.2: Products offered for Single Cell Genomics
  • Table 5.3: Key Developments in Single Cell Transcriptomics and Proteomics Market
  • Table 5.4: Products offered for Single Cell Transcriptomics and Proteomics
  • Table 5.5: Developments in the Techniques for Single Cell Metabolomics
  • Table 5.6: Products offered for Single Cell Metabolomics
  • Table 7.1: Products for Fluorescence-activated Cell Sorting
  • Table 7.2: Products for Manual Cell Picking
  • Table 7.3: Products for Magnetic-activated Cell Sorting
  • Table 7.4: Products for Laser Microdissection
  • Table 7.5: Products for Random Seeding/ Limited Dilution
  • Table 7.6: Products for Microfluidics
  • Table 7.7: Others Products Available for Single Cell Isolation
  • Table 7.8: Products for Microfluidics
  • Table 7.9: Products for Whole Genome Amplification
  • Table 7.10: Products for Single Cell RNA-seq
  • Table 7.11: PCR Based Products for Single Cell Isolation
  • Table 7.12: NGS Based Products for Single Cell Isolation
  • Table 7.13: PCR Based Products for Single Cell Isolation
  • Table 7.14: Multiple Displacement Amplification Based Products for Single Cell Analysis
  • Table 7.15: Multiple Annealing and Looping-based Amplification Based Products for Single Cell Analysis
  • Table 7.16: Flow Cytometry Based Products for Single Cell Analysis
  • Table 7.17: Mass Spectrometry Based Products for Single Cell Analysis
  • Table 7.18: Advanced Techniques for Live Cell Imaging
  • Table 7.19: Mass Spectrometry Based Products for Single Cell Analysis
  • Table 7.20: Microfluidics Based Products for Single Cell Analysis
  • Table 7.21: In-Vitro Transcription Based Products for Single Cell Analysis
  • Table 7.22: phi29 DNA Polymerase Based Products for Single Cell Analysis

List of Figures

  • Figure 1: Drivers and Restraints of Next-Generation Sequencing Market
  • Figure 2: Key Strategies Incorporated by Stakeholders of NGS Market, to Sustain the Competition (from January 2016 to April 2019)
  • Figure 3: Global Single Cell Multi-Omics Market Snapshot
  • Figure 4: Dominating Segments of Global Single Cell Multi-Omics, 2018 and 2025
  • Figure 5: Global Single Cell Multi-Omics Market Share (By Product), 2018-2025
  • Figure 6: Global Single Cell Multi-Omics Market Share (By Technology), 2018-2025
  • Figure 7: Global Single Cell Multi-Omics Market Share (By Workflow), 2018-2025
  • Figure 8: Global Single Cell Multi-Omics Market Share (By End-User), 2018-2025
  • Figure 9: Global Single Cell Multi-Omics Market Share (By Application), 2018-2025
  • Figure 1.1: Single Cell Multi-Omics Approach
  • Figure 1.2: Evolution of Single Cell Multi-Omics Technology
  • Figure 1.3: Global Single Cell Multi-Omics Market Size, 2018-2025
  • Figure 1.4: Three Major Technological Development in Single Cell Sequencing
  • Figure 1.5: Traditional and Modern Approaches for Single Cell Isolation
  • Figure 2.1: Market Dynamics of Global Single Cell Multi-Omics Market
  • Figure 3.1: North America Single Cell Multi-Omics Addressable Market by 2025
  • Figure 3.2: Europe Single Cell Multi-Omics Addressable Market by 2025
  • Figure 3.3: Asia-pacific Single Cell Multi-Omics Addressable Market by 2025
  • Figure 3.4: Latin America Single Cell Multi-Omics Addressable Market by 2025
  • Figure 3.5: Rest of World Single Cell Multi-Omics Addressable Market by 2025
  • Figure 4.1: Share of Key Developments and Strategies, (January 2016 - April 2019)
  • Figure 4.2: Product Launches Share (by Companies), January 2016 - April 2019
  • Figure 4.3: Synergistic Activities Share (by Companies), January 2016 - April 2019
  • Figure 4.4: Acquisitions Share (by Companies), January 2016 - April 2019
  • Figure 4.5: Funding Share (by Companies), January 2016 - April 2019
  • Figure 4.6: Overall Industry Attractiveness, 2018 and 2025
  • Figure 4.7: Overall Impact of Bargaining Power of Suppliers
  • Figure 4.8: Overall Impact of Bargaining Power of Buyers
  • Figure 4.9: Overall Impact of Threat of New Entrants
  • Figure 4.10: Overall Impact of Threat of Substitute Products
  • Figure 4.11: Overall Impact of Intensity of Competitive Rivalry
  • Figure 5.1: Types of Omics Platforms
  • Figure 5.2: Global Single Cell Genomics Market, 2018-2025
  • Figure 5.3: Global Single Cell Transcriptomics and Proteomics Market, 2018-2025
  • Figure 5.4: Global Single Cell Metabolomics Market, 2018-2025
  • Figure 6.1: Global Single Cell Multi-Omics Market (by Product Type)
  • Figure 6.2: Global Single Cell Multi-Omics (by Product Type), 2018 and 2025
  • Figure 6.3: Global Single Cell Multi-Omics Instruments Market, 2018-2025
  • Figure 6.4: Global Single Cell Multi-Omics FACS Market, 2018-2025
  • Figure 6.5: Global Single Cell Multi-Omics NGS System Market, 2018-2025
  • Figure 6.6: Global Single Cell Multi-Omics PCR Market, 2018-2025
  • Figure 6.7: Global Single Cell Multi-Omics Microscopes Market, 2018-2025
  • Figure 6.8: Global Single Cell Multi-Omics Microarray Systems Market, 2018-2025
  • Figure 6.9: Global Single Cell Multi-Omics Spectrophotometers Market, 2018-2025
  • Figure 6 10: Global Single Cell Multi-Omics Microplate Readers Market, 2018-2025
  • Figure 6.11: Global Single Cell Multi-Omics Cell Counter Market, 2018-2025
  • Figure 6.12: Global Single Cell Multi-Omics Cell Sorters Market, 2018-2025
  • Figure 6.13: Global Single Cell Multi-Omics Others Market, 2018-2025
  • Figure 6.14: Global Single Cell Multi-Omics Consumables Market, 2018-2025
  • Figure 6.15: Global Single Cell Multi-Omics Beads Market, 2018-2025
  • Figure 6.16: Global Single Cell Multi-Omics Microplates Market, 2018-2025
  • Figure 6.17: Global Single Cell Multi-Omics Microplates Market, 2018-2025
  • Figure 6.18: Global Single Cell Multi-Omics Reagents Market, 2018-2025
  • Figure 6.19: Global Single Cell Multi-Omics Consumables Market (Others), 2018-2025
  • Figure 7.1: Single Cell Isolation Methods
  • Figure 7.2: Global Single Cell Isolation Market, 2018-2025
  • Figure 7.3: Global Single Cell Flow Cytometry/FACS Market, 2018-2025
  • Figure 7.4: Global Single Cell Manual Cell Picking Market, 2018-2025
  • Figure 7.5: Global Single Cell Magnetic-activated Cell Sorting (MACS) Market, 2018-2025
  • Figure 7.6: Global Single Cell Laser Microdissection Market, 2018-2025
  • Figure 7.7: Global Single Cell Random Seeding/ Limiting Dilution Market, 2018-2025
  • Figure 7.8: Global Single Cell Microfluidics Market, 2018-2025
  • Figure 7.9: Global Single Cell Isolation Market (Others), 2018-2025
  • Figure 7.10: Sample Preparation Workflow
  • Figure 7.11: Methods for Single Cell Preparation
  • Figure 7.12: Global Single Cell Preparation Market, 2018-2025
  • Figure 7.13: Global Single Cell Preparation Microfluidics Market, 2018-2025
  • Figure 7.14: Global Single Cell Preparation Whole Genome Amplification Market, 2018-2025
  • Figure 7.15: Techniques for Whole Genome Amplification
  • Figure 7.16: Global Single Cell Preparation Single Cell RNA Sequencing, 2018-2025
  • Figure 7.17: Global Single Cell Preparation Market (Others), 2018-2025
  • Figure 7.18: Global Single Cell Analysis Market, 2018-2025
  • Figure 7.19: Global Single Cell Analysis Polymerase Chain Reaction Market, 2018-2025
  • Figure 7.20: Global Single Cell Analysis Next-Generation Sequencing Market, 2018-2025
  • Figure 7.21: Global Single Cell Analysis Microarray Market, 2018-2025
  • Figure 7.22: Global Single Cell Analysis Multiple Displacement Amplification Market, 2018-2025
  • Figure 7.23: Global Single Cell Analysis Multiple Annealing and Looping-based Amplification, 2018-2025
  • Figure 7.24: Global Single Cell Flow Cytometry Market, 2018-2025
  • Figure 7.25: Global Single Cell Analysis Mass Spectrometry Market, 2018-2025
  • Figure 7.26: Global Single Cell Analysis Microscopy Market, 2018-2025
  • Figure 7.27: Global Single Cell Microfluidics Market, 2018-2025
  • Figure 7.28: Global Single Cell Analysis Market (Others), 2018-2025
  • Figure 8.1: Global Single Cell Multi-Omics Market, By Research and Academia, 2018-2025
  • Figure 8.2: Global Single Cell Multi-Omics Market, By Biopharmaceutical and Biotech Companies, 2018-2025
  • Figure 8.3: Global Single Cell Multi-Omics Market, By Hospitals, Clinics and Diagnostic Labs (Others), 2018-2025
  • Figure 9.1: Global Single Cell Multi-Omics Market (by Region), 2018 and 2025
  • Figure 9.2: Global Single Cell Multi-Omics Market (by Region), 2018-2025
  • Figure 9.3: Global Single Cell Multi-Omics Market Share (by Region), 2018
  • Figure 9.4: Global Single cell multi-omics Market Share (by Region), 2025
  • Figure 9.5: North America Global Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.6: North America: Market Dynamics
  • Figure 9.7: North America Single Cell Multi-Omics Market (By Country), 2018-2025
  • Figure 9.8: The U.S. Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.9: Canada Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.10: Europe Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.11: Europe: Market Dynamics
  • Figure 9.12: Europe Global Single Cell Multi-Omics Market (by Country), 2018-2025
  • Figure 9.13: Germany Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.14: France Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.15: The U.K. Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.16: Italy Single Cell Multi-Omics Market, 2018-2025
  • Figure 9 17: Spain Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.18: Rest-of-Europe Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.19: Asia-Pacific Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.20: APAC: Market Dynamics
  • Figure 9.21: APAC Single Cell Multi-Omics Market (by Country), 2018-2025
  • Figure 9.22: Japan Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.23: Singapore Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.24: India Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.25: China Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.26: South Korea Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.27: Australia Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.28: RoAPAC Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.29: Latin America Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.30: Latin America: Market Dynamics
  • Figure 9.31: Latin America Single Cell Multi-Omics Market (by Country), 2018-2025
  • Figure 9.32: Mexico Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.33: Brazil Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.34: Rest-of-Latin America Single Cell Multi-Omics Market, 2018-2025
  • Figure 9.35: RoW Single Cell Multi-Omics Market, 2018-2025
  • Figure 10.1: Applications of Single-Cell Multi-Omics
  • Figure 10.2: Global Single Cell Multi-Omics Market for Oncology Application (2018-2025)
  • Figure 10.3: Method for single cell RNA sequencing methods
  • Figure 10.4: Global Single Cell Multi-Omics Market for Immunology Application (2018-2025)
  • Figure 10.5: Global Single Cell Multi-Omics Market for Neurology Application (2018-2025)
  • Figure 10.6: Global Single Cell Multi-Omics Market for Microbiology Application (2018-2025)
  • Figure 10.7: Global Single Cell Multi-Omics Stem Cell Market (2018-2025)
  • Figure 10.8: Global Single Cell Multi-Omics Cell Biology Market (2018-2025)
  • Figure 10.9: Global Single Cell Multi-Omics Other Application Market (2018-2025)
  • Figure 11.1: Growth Share Matrix for Global Single Cell Multi-Omics Market (by Companies), 2018
  • Figure 11.2: Market Share Analysis for the Global Single Cell Multi-Omics Market, 2018
  • Figure 11.3: Components of Value Chain
  • Figure 11.4: Value Chain Analysis of Medical Device Industry
  • Figure 11.5: Supply Chain Analysis of a Medical Device Industry
  • Figure 12.1: Shares of Key Company Profiles
  • Figure 12.2: 1CellBio: SWOT Analysis
  • Figure 12.3: 10x Genomics Inc.: SWOT Analysis
  • Figure 12.4: Becton, Dickinson and Company: Overall Financials, 2016-2018
  • Figure 12.5: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2018
  • Figure 12.6: Becton, Dickinson and Company: Revenue (by Region), 2015-2018
  • Figure 12.7: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
  • Figure 12.8: Becton, Dickinson and Company: SWOT Analysis
  • Figure 12.9: Bio-Rad Laboratories, Inc.: Overall Financials, (2016-2018)
  • Figure 12.10: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 12.11: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
  • Figure 12.12: Bio-Rad Laboratories, Inc., R&D Expenditure, 2016-2018
  • Figure 12.13: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 12.14: BGI: SWOT Analysis
  • Figure 12.15: Celsee Inc.: SWOT Analysis
  • Figure 12.16: Fluidigm Corporation: Overall Financials, 2016-2018
  • Figure 12.17: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 12.18: Fluidigm Corporation: Revenue (by Region), 2016-2018
  • Figure 12.19: Fluidigm Corporation: R&D Expenditure, 2016-2018
  • Figure 12.20: Fluidigm Corporation: SWOT Analysis
  • Figure 12.21: Fluxion Biosciences: SWOT Analysis
  • Figure 12.22: GE: Revenue (by Business Segment), 2015-2018
  • Figure 12.23: GE: Revenue (Healthcare), 2016-2018
  • Figure 12.24: GE Healthcare: Revenue (by Business Segment), 2015-2018
  • Figure 12.25: GE: R&D Expenditure, 2016-2018
  • Figure 12.26: GE: R&D Expenditure (By Segment), 2015-2018
  • Figure 12.27: GE: Overall Financials, (2016-2018)
  • Figure 12.28: GE: Revenue (by Business Segment), 2016-2018
  • Figure 12.29: GE: Revenue (Healthcare), 2016-2018
  • Figure 12.30: GE Healthcare: Revenue (by Business Segment), 2016-2018
  • Figure 12.31: GE: R&D Expenditure, 2016-2018
  • Figure 12.32: GE: R&D Expenditure (By Segment), 2016-2018
  • Figure 12.33: GE: SWOT Analysis
  • Figure 12.34: Mission Bio: SWOT Analysis
  • Figure 12.35: NanoString Technologies, Inc.: Overall Financials, (2016-2018)
  • Figure 12.36: NanoString Technologies, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 12.37: NanoString Technologies, Inc.: Revenue (by Region), 2016-2018
  • Figure 12.38: NanoString Technologies, Inc.: R&D Expenditure, 2016-2018
  • Figure 12.39: NanoString Technologies, Inc.: R&D Expenditure (By Functional Area), 2016-2018
  • Figure 12.40: NanoString Technologies: SWOT Analysis
  • Figure 12.41: Illumina Inc.: Overall Financials, (2016-2018)
  • Figure 12.42: Illumina, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 12.43: Illumina, Inc.: Revenue (by Region), 2016-2018
  • Figure 12.44: Illumina, Inc., R&D Expenditure, 2016-2018
  • Figure 12.45: Illumina, Inc. SWOT Analysis
  • Figure 12.46: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
  • Figure 12.47: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 12.48: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
  • Figure 12.49: PerkinElmer, Inc., Inc.: R&D Expenditure, 2016-2018
  • Figure 12.50: PerkinElmer, Inc.: SWOT Analysis
  • Figure 12.51: QIAGEN N.V..: Overall Financials, (2015-2017)
  • Figure 12.52: QIAGEN N.V.: Revenue (by Business Segment), 2015-2017
  • Figure 12.53: QIAGEN N.V.: Revenue (by Region), 2015-2017
  • Figure 12.54: QIAGEN N.V.: R&D Expenditure, 2015-2017
  • Figure 12.55: QIAGEN N.V.: SWOT Analysis
  • Figure 12.56: Takara Bio Inc.: Overall Financials, (2016-2018)
  • Figure 12.57: Takara Bio, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 12.58: Takara Bio, Inc.: Revenue (by Region), 2017
  • Figure 12.59: Takara Bio, Inc., R&D Expenditure, 2015-2017
  • Figure 12.60: Takara Bio Inc.: SWOT Analysis
  • Figure 13.1: Global Single Cell Multi-Omics Market Segmentation
  • Figure 13.2: Global Single Cell Multi-Omics Market Research Methodology
  • Figure 13.3: Primary Research
  • Figure 13.4: Secondary Research
  • Figure 13.5: Data Triangulation
  • Figure 13.6: Bottom-up Approach (Segment-wise Analysis)
  • Figure 13.7: Top-down Approach (Segment-wise Analysis)
  • Figure 13.8: Assumptions and Limitations
  • Figure 13.9: Considered Factors for Data Prediction and Modeling
Back to Top